Insider Trading June 25, 2026 05:00 PM

Clean Energy Fuels Director Stephen Scully Acquires Shares Amid Operational Expansions

Insider buying coincides with Q1 earnings beat and infrastructure development in Puerto Rico and Idaho.

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
CLNE

Clean Energy Fuels Corp. (NASDAQ:CLNE) director Stephen Scully executed a recent acquisition of the company's equity, purchasing 25,000 shares on June 25, 2026. The transaction valued at $43,725 occurred while the stock was trading near its 52-week low. This insider activity follows a quarter where Clean Energy Fuels reported financial results that surpassed analyst forecasts. Concurrently, the company has advanced its operational footprint through new contracts in Puerto Rico and the completion of a renewable natural gas facility in Idaho.

Clean Energy Fuels Director Stephen Scully Acquires Shares Amid Operational Expansions
CLNE
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Clean Energy Fuels reported Q1 2026 earnings that surpassed analyst expectations, with EPS of -$0.01 beating the forecast of -$0.03, and revenue of $117.6 million exceeding the projection of $100.48 million.
  • The company secured two contracts in Puerto Rico to design and install LNG fueling systems for power generation, specifically for a pharmaceutical manufacturer, and completed its eighth renewable natural gas facility in Idaho.
  • Bart Frabotta was appointed as Chief Operating Officer, taking over the operations division and becoming a named executive officer after serving at the company since 2010.

Stephen Scully, serving as a director for Clean Energy Fuels Corp. (NASDAQ:CLNE), has executed a purchase of the company's equity. On June 25, 2026, Scully acquired 25,000 shares of common stock. The transaction carried a total value of $43,725. The shares were purchased at prices ranging from $1.745 to $1.75 per share, resulting in a weighted average price of $1.749 per share.

Following this acquisition, Mr. Scully, acting through a family trust, indirectly holds 360,244 shares of Clean Energy Fuels common stock.

Insider buying activity emerges as CLNE trades at $1.79. This price point sits near the company's 52-week low of $1.66. The stock has declined 43% from its 52-week high of $3.11. According to InvestingPro analysis, the stock appears undervalued with a Fair Value of $2.58. This valuation places CLNE among opportunities on the platform's Most Undervalued list. An InvestingPro tip notes the RSI suggests oversold territory, potentially signaling a buying opportunity. The company carries a market cap of $390 million and maintains an overall "FAIR" financial health rating. Investors seeking deeper analysis can access the comprehensive Pro Research Report, available for CLNE and 1,400+ US equities.

In other recent news, Clean Energy Fuels Corp. reported its Q1 2026 earnings, surpassing analyst expectations with an earnings per share (EPS) of -$0.01, outperforming the forecasted -$0.03. The company also exceeded revenue projections, posting $117.6 million compared to the anticipated $100.48 million.

Additionally, Clean Energy Fuels has secured two contracts in Puerto Rico to design and install liquefied natural gas fueling systems for power generation. These contracts involve providing LNG station equipment and installation for a global healthcare supplier's pharmaceutical manufacturing operations on the island.

In Idaho, Clean Energy Fuels completed its eighth dairy renewable natural gas production facility at East Valley Cattle. The facility features six anaerobic digesters to capture methane from cow manure. The facility began producing and injecting renewable natural gas into the interstate pipeline for transportation fuel use.

Furthermore, the company announced the appointment of Bart Frabotta as Chief Operating Officer. Frabotta has been with the company since 2010. Frabotta will oversee the operations division and become one of the named executive officers.

The stock data indicates a closing price of 1.795, representing a change of +0.065 or +3.76%. After hours trading showed a price of 1.825, a change of +0.035 or +1.95%. The article was generated with the support of AI and reviewed by an editor. For more information see our T&C.


Is CLNE a bargain right now? The fastest way to find out is with our Fair Value calculator. We use a mix of 17 proven industry valuation models for maximum accuracy. Get the bottom line for CLNE plus thousands of other stocks and find your next hidden gem with massive upside. See Undervalued Stocks

Risks

  • The stock trades at $1.79, which is near its 52-week low of $1.66 and down 43% from its 52-week high of $3.11, indicating significant price volatility and potential market skepticism.
  • The company carries an overall "FAIR" financial health rating, which may suggest underlying financial challenges or limited margin for error in its operational execution.
  • The acquisition of stock by director Stephen Scully occurs while the stock is trading near its 52-week low, which may reflect uncertainty about near-term price recovery despite the insider purchase.

More from Insider Trading

Avalo Therapeutics CMO Mittie Doyle Executes $26,100 Share Sale Under Pre-Arranged Plan Jun 25, 2026 908 Devices Director Brown Offloads $89,495 in Pre-IPO Equity Jun 25, 2026 908 Devices CEO Kevin Knopp Executes Pre-Arranged Stock Sales Amid Valuation Concerns Jun 25, 2026 Royalty Pharma Executive Sells Shares Under Pre-Arranged Plan Jun 25, 2026 WidePoint COO Todd Dzyak Offloads $240,000 in WYY Shares Amid Strong Stock Performance Jun 25, 2026